FDA Drug Recalls

Recalls / Class II

Class IID-0676-2022

Product

Desoximetasone Ointment USP, 0.05%, Net Wt. 100 grams tubes, Rx only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70810, NDC 70512-037-10.

Affected lot / code info
Batch: 15996, 15997, Exp. 9/30/2022

Why it was recalled

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Recalling firm

Firm
Teligent Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
105 Lincoln Avenue, N/A, Buena, New Jersey 08310

Distribution

Quantity
6850 tubes
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2022-03-15
FDA classified
2022-03-21
Posted by FDA
2022-03-30
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0676-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls